Evaluation and Validation Studies on Asbestos

PubMed, the National Library of Medicine's index of medical journals, labels every article with its publication type. 187 studies in our library are labeled as studies that measure how well a test, method or program works. The labels are NLM's, not ours. Each entry links to the study on PubMed and to its journal's page in our library, where you can read the abstract.

2020s

• Design and validation of instruments of working conditions associated with silica and asbestos exposure. C. Antolinez-Figueroa, L.Y.C. Castillo, J.M. Sierra, et al. Annals of Work Exposures and Health 2026;70(8). PubMed · Publisher · Free full text
• Lung cancer risk prediction models and asbestos exposure: a validation study on the Western Australia Asbestos Review Program. C. Kumarasamy, K. Betts, R. Norman, et al. Occupational and Environmental Medicine 2026;83(3):154-161. PubMed · Publisher · Free full text
• Prospective validation of an artificial intelligence assessment in a cohort of applicants seeking financial compensation for asbestosis (PROSBEST). I. Smesseim, K.B.W.G. Lipman, S. Trebeschi, et al. European Radiology Experimental 2025;9(1):76. PubMed · Publisher · Free full text
• Combined grade and nuclear grade are prognosis predictors of epithelioid malignant peritoneal mesothelioma: a multi-institutional retrospective study. N. Benzerdjeb, P. Dartigues, V. Kepenekian, et al. Virchows Archiv 2021;479(5):927-936. PubMed · Publisher
• Development of rapid and highly accurate method to measure concentration of fibers in atmosphere using artificial intelligence and scanning electron microscopy. Y. Iida, K. Watanabe, Y. Ominami, et al. Journal of Occupational Health 2021;63(1):e12238. PubMed · Publisher · Free full text
• DNA Methylation Profiling Discriminates between Malignant Pleural Mesothelioma and Neoplastic or Reactive Histologic Mimics. L. Bertero, L. Righi, G. Collemi, et al. The Journal of Molecular Diagnostics 2021;23(7):834-846. PubMed · Publisher
• Malignant peritoneal mesothelioma: prognostic significance of clinical and pathologic parameters and validation of a nuclear-grading system in a multi-institutional series of 225 cases. D.B. Chapel, J.J. Schulte, G. Absenger, et al. Modern Pathology 2021;34(2):380-395. PubMed · Publisher
• Differentiating Between Malignant Mesothelioma and Other Pleural Lesions Using Fourier Transform Infrared Spectroscopy. F. Sadiku-Zehri, O. Gamulin, M. Škrabić, et al. Applied Spectroscopy 2020;74(7):808-818. PubMed · Publisher
• Repurposing Quinacrine for Treatment of Malignant Mesothelioma: In-Vitro Therapeutic and Mechanistic Evaluation. N.S. Kulkarni, B. Vaidya, V. Parvathaneni, et al. International Journal of Molecular Sciences 2020;21(17). PubMed · Publisher · Free full text
• Usefulness of methylthioadenosine phosphorylase and BRCA-associated protein 1 immunohistochemistry in the diagnosis of malignant mesothelioma in effusion cytology specimens. K.B. Berg, A.M. Churg, S. Cheung, et al. Cancer Cytopathology 2020;128(2):126-132. PubMed · Publisher
• Validation of an Asbestos Exposure Questionnaire (QEAS-7) for Clinical Practice. J. Ferrer, G. Granados, S. Hernández, et al. International Journal of Environmental Research and Public Health 2020;17(24). PubMed · Publisher · Free full text

2010s

• 3-Dimensional Quantification of Composite Pleural Plaque Volume in Patients Exposed to Asbestos Using High-resolution Computed Tomography: A Validation Study. G. Dournes, A. Dubois, I. Benlala, et al. Journal of Thoracic Imaging 2019;34(5):320-325. PubMed · Publisher

• A Monte Carlo t Test to Evaluate Mesothelioma and Radiation in the US Transuranium and Uranium Registries. J.Y. Zhou, S.L. McComish, S.Y. Tolmachev. Health Physics 2019;117(2):187-192. PubMed · Publisher

• A novel diagnostic method for distinguishing parapneumonic effusion and empyema from other diseases by using the pleural lactate dehydrogenase to adenosine deaminase ratio and carcinoembryonic antigen levels. T. Saraya, K. Ohkuma, T. Koide, et al. Medicine 2019;98(13):e15003. PubMed · Publisher · Free full text

• A Novel Prospective Study Assessing the Combination of Photodynamic Therapy and Proton Radiation Therapy: Safety and Outcomes When Treating Malignant Pleural Mesothelioma. S.R. Rice, Y.R. Li, T.M. Busch, et al. Photochemistry and Photobiology 2019;95(1):411-418. PubMed · Publisher · Free full text

• Evaluation of Matrix Metalloproteinase 9 Serum Concentration as a Biomarker in Malignant Mesothelioma. D. Štrbac, K. Goričar, V. Dolžan, et al. Disease Markers 2019;2019:1242964. PubMed · Publisher · Free full text

• External validation and recalibration of the Brock model to predict probability of cancer in pulmonary nodules using NLST data. A. Winter, D.R. Aberle, W. Hsu. Thorax 2019;74(6):551-563. PubMed · Publisher

• Loco-regional staging of malignant pleural mesothelioma by integrated 18F-FDG PET/MRI. D.J. Murphy, S.M. Mak, A. Mallia, et al. European Journal of Radiology 2019;115:46-52. PubMed · Publisher

• Prevalence and Preliminary Validation of Screening Criteria to Identify Carriers of Germline BAP1 Mutations. M.G. Zauderer, G. Jayakumaran, M. DuBoff, et al. Journal of Thoracic Oncology 2019;14(11):1989-1994. PubMed · Publisher · Free full text

• Probability of cancer in lung nodules using sequential volumetric screening up to 12 months: the UKLS trial. M.W. Marcus, S.W. Duffy, A. Devaraj, et al. Thorax 2019;74(8):761-767. Randomized trial PubMed · Publisher

• Accuracy of a mobile app to identify suspect asbestos-containing material in Australian residential settings. M.H. Govorko, L. Fritschi, A. Reid. Journal of Occupational and Environmental Hygiene 2018;15(8):598-606. PubMed · Publisher

• FDG PET-derived parameters as prognostic tool in progressive malignant pleural mesothelioma treated patients. E. Incerti, S. Broggi, A. Fodor, et al. European Journal of Nuclear Medicine and Molecular Imaging 2018;45(12):2071-2078. PubMed · Publisher

• Genomic Deletion of BAP1 and CDKN2A Are Useful Markers for Quality Control of Malignant Pleural Mesothelioma (MPM) Primary Cultures. K.H. Sarun, K. Lee, M. Williams, et al. International Journal of Molecular Sciences 2018;19(10). PubMed · Publisher · Free full text

• Loss of BRCA1-associated protein 1 (BAP1) expression is useful in diagnostic cytopathology of malignant mesothelioma in effusions. I. Cozzi, F.A. Oprescu, E. Rullo, et al. Diagnostic Cytopathology 2018;46(1):9-14. PubMed · Publisher

• Relation between neutrophil/lymphocyte ratio and primary tumor metabolic activity in patients with malign pleural mesothelioma. B.A. Özyürek, Ö. Özmen, T.Ş. Özdemirel, et al. The Clinical Respiratory Journal 2018;12(2):646-651. PubMed · Publisher

• Validation of the diagnosis of mesothelioma and BAP1 protein expression in a cohort of asbestos textile workers from Northern Italy. P. Boffetta, L. Righi, C. Ciocan, et al. Annals of Oncology 2018;29(2):484-489. PubMed · Publisher

• Validity of the Lymphocyte Cytokinesis-Block Micronucleus Assay (L-CBMN) as biomarker for human exposure to chemicals with different modes of action: A synthesis of systematic reviews. M. Kirsch-Volders, M. Fenech, C. Bolognesi. Mutation Research. Genetic Toxicology and Environmental Mutagenesis 2018;836(Pt A):47-52. PubMed · Publisher

• EpCAM-independent capture of circulating tumor cells with a 'universal CTC-chip'. Y. Chikaishi, K. Yoneda, T. Ohnaga, et al. Oncology Reports 2017;37(1):77-82. PubMed · Publisher

• Evaluating the effect of immune cells on the outcome of patients with mesothelioma. S.J. Chee, M. Lopez, T. Mellows, et al. British Journal of Cancer 2017;117(9):1341-1348. PubMed · Publisher · Free full text

• Evaluation of take-home exposure to asbestos from handling asbestos-contaminated worker clothing following the abrasive sawing of cement pipe. A. Abelmann, J.R. Maskrey, J.T. Lotter, et al. Inhalation Toxicology 2017;29(12-14):555-566. PubMed · Publisher

• Exhaled breath to screen for malignant pleural mesothelioma: a validation study. K. Lamote, M. Vynck, O. Thas, et al. The European Respiratory Journal 2017;50(6). PubMed · Publisher

• External validation of prognostic indices for overall survival of malignant pleural mesothelioma. Y. Kataoka, Y. Yamamoto, T. Otsuki, et al. Lung Cancer 2017;113:88-92. PubMed · Publisher

• Real-time PCR assay for the diagnosis of pleural tuberculosis. M.A. Casallas-Rivera, A.M. Cárdenas Bernal, L.F. Giraldo-Cadavid, et al. Colombia Médica 2017;48(2):47-52. PubMed · Free full text

• The analysis of novel microRNA mimic sequences in cancer cells reveals lack of specificity in stem-loop RT-qPCR-based microRNA detection. P. Winata, M. Williams, E. McGowan, et al. BMC Research Notes 2017;10(1):600. PubMed · Publisher · Free full text

• The importance of EZH2 and MOC-31 expression in the differential diagnosis of benign and malignant effusions. C. Sadullahoglu, D. Nart, A. Veral. Diagnostic Cytopathology 2017;45(2):118-124. PubMed · Publisher

• Utility of CEA and CA 15-3 measurements in non-purulent pleural exudates in the diagnosis of malignancy: A single-center experience. J.M. Porcel, C. Civit, A. Esquerda, et al. Archivos de Bronconeumología 2017;53(8):427-431. In English, Spanish. PubMed · Publisher

• Validation of a Gene Expression Test for Mesothelioma Prognosis in Formalin-Fixed Paraffin-Embedded Tissues. A. De Rienzo, R.W. Cook, J. Wilkinson, et al. The Journal of Molecular Diagnostics 2017;19(1):65-71. PubMed · Publisher · Free full text

• BAP1 Immunostain and CDKN2A (p16) FISH Analysis: Clinical Applicability for the Diagnosis of Malignant Mesothelioma in Effusions. A.E. Walts, K. Hiroshima, S.M. McGregor, et al. Diagnostic Cytopathology 2016;44(7):599-606. PubMed · Publisher

• CD24 is highly useful in differentiating high-grade serous carcinoma from benign and malignant mesothelial cells. B. Davidson. Human Pathology 2016;58:123-127. PubMed · Publisher

• Evaluation of asbestos-containing products and released fibers in home appliances. S.H. Hwang, W.M. Park. Journal of the Air & Waste Management Association 2016;66(9):922-9. PubMed · Publisher

• GATA-3 and FOXA1 expression is useful to differentiate breast carcinoma from other carcinomas. D.G. Davis, M.T. Siddiqui, G. Oprea-Ilies, et al. Human Pathology 2016;47(1):26-31. PubMed · Publisher

• Illumination profile characterization of a light device for the dosimetry of intra-pleural photodynamic therapy for mesothelioma. C. Munck, S. Mordon, N. Betrouni. Photodiagnosis and Photodynamic Therapy 2016;16:23-26. PubMed · Publisher

• Immunocytochemical utility of claudin-4 versus those of Ber-EP4 and MOC-31 in effusion cytology. T. Oda, S. Ogata, S. Kawaguchi, et al. Diagnostic Cytopathology 2016;44(6):499-504. PubMed · Publisher

• Immunohistochemistry for NF2, LATS1/2, and YAP/TAZ Fails to Separate Benign From Malignant Mesothelial Proliferations. B.S. Sheffield, J. Lorette, Y. Shen, et al. Archives of Pathology & Laboratory Medicine 2016;140(5):391. Letter PubMed · Publisher

• Long-term outcomes following post-operative radiotherapy for Stage I/II testicular seminoma - an Australasian single-institution experience. W.L. Ong, L. Nazareth, B. Hindson, et al. Journal of Medical Radiation Sciences 2016;63(3):161-9. PubMed · Publisher · Free full text

• MMP-7 is a highly specific negative marker for benign and malignant mesothelial cells in serous effusions. B. Davidson, H.T. Stavnes, E. Hellesylt, et al. Human Pathology 2016;47(1):104-8. PubMed · Publisher

• Specimen weight and volume: important predictors of survival in malignant pleural mesothelioma. D.Y. Kircheva, A.N. Husain, S. Watson, et al. European Journal of Cardio-thoracic Surgery 2016;49(6):1642-7. PubMed · Publisher

• The diagnostic utility of reduced immunohistochemical expression of SMARCB1 in synovial sarcomas: a validation study. J. Ito, N. Asano, A. Kawai, et al. Human Pathology 2016;47(1):32-7. PubMed · Publisher

• The Role of 18F-FDG PET/CT Integrated Imaging in Distinguishing Malignant from Benign Pleural Effusion. Y. Sun, H. Yu, J. Ma, et al. PloS One 2016;11(8):e0161764. PubMed · Publisher · Free full text

• The utility of the in vitro micronucleus test for evaluating the genotoxicity of natural and manmade nano-scale fibres. P. Fowler, A. Homan, D. Atkins, et al. Mutation Research. Genetic Toxicology and Environmental Mutagenesis 2016;809:33-42. PubMed · Publisher

• Validity of mesothelin in occupational medicine practice. P. Smolková, M. Nakládalová, J. Zapletalová, et al. International Journal of Occupational Medicine and Environmental Health 2016;29(3):395-404. PubMed · Publisher

• BAP1 (BRCA1-associated protein 1) is a highly specific marker for differentiating mesothelioma from reactive mesothelial proliferations. M. Cigognetti, S. Lonardi, S. Fisogni, et al. Modern Pathology 2015;28(8):1043-57. PubMed · Publisher

• BAP1 immunohistochemistry and p16 FISH to separate benign from malignant mesothelial proliferations. B.S. Sheffield, H.C. Hwang, A.F. Lee, et al. The American Journal of Surgical Pathology 2015;39(7):977-82. PubMed · Publisher

• Comparative long-term toxicity of Libby amphibole and amosite asbestos in rats after single or multiple intratracheal exposures. J.M. Cyphert, D.J. Carlin, A. Nyska, et al. Journal of Toxicology and Environmental Health. Part a 2015;78(3):151-65. PubMed · Publisher

• Effect of Organic Manures on the Growth of Cymbopogon citratus and Chrysopogon zizanioides for the Phytoremediation of Chromite-Asbestos Mine Waste: A Pot Scale Experiment. A. Kumar, S.K. Maiti. International Journal of Phytoremediation 2015;17(1-6):437-47. PubMed · Publisher

• Evaluation of androgen receptor and GATA binding protein 3 as immunohistochemical markers in the diagnosis of metastatic breast carcinoma to the lung. Y. Hattori, A. Yoshida, M. Yoshida, et al. Pathology International 2015;65(6):286-92. PubMed · Publisher

• Evaluation of the dark-medium objective lens in counting asbestos fibers by phase-contrast microscopy. E.G. Lee, J.H. Nelson, M.L. Kashon, et al. The Annals of Occupational Hygiene 2015;59(5):616-28. PubMed · Publisher · Free full text

  In plain English

  This laboratory methods study looked at how the choice of microscope lens affects counts of asbestos fibers under phase-contrast microscopy, the standard method for measuring airborne asbestos. It did not study health effects. Nine laboratories counted fibers on 15 proficiency-testing reference slides (ten chrysotile, five amosite). All of them used the same circulated Nikon microscope, counting once with a standard objective lens (DLL, numerical aperture 0.75) and once with a 'dark-medium' (DM) lens (numerical aperture 0.95). Six of the labs then counted six chrysotile slides made from older workplace air samples whose site is unknown. With the DM lens, counts on the chrysotile reference slides were significantly higher; the authors give 1.45 times for all data. Counts did not differ significantly between the two lenses for the amosite reference slides or the chrysotile field slides. Test slides and a diatom test plate showed no consistent differences between the lenses in visibility or resolution. The authors concluded that the greater contrast of the DM lens was the main cause of the higher counts. They concluded the DM lens could be allowed for routine counting, although published standard methods would need to be changed. They noted that the field results came from only six slides from a single site.

  We wrote this plain-English summary from the full article with the help of AI, and a second AI model checked each sentence against the article. It is not the authors' wording; the abstract and the article are their own account.

• Immunohistochemical Evaluation of Minichromosome Maintenance Protein 7 (MCM7), Topoisomerase IIα, and Ki-67 in Diffuse Malignant Peritoneal Mesothelioma Patients Using Tissue Microarray. M. Deraco, A. Cabras, D. Baratti, et al. Annals of Surgical Oncology 2015;22(13):4344-51. PubMed · Publisher

• Malignant pleural mesothelioma: visual assessment by using pleural pointillism at diffusion-weighted MR imaging. J. Coolen, F. De Keyzer, P. Nafteux, et al. Radiology 2015;274(2):576-84. PubMed · Publisher

• Peritoneal carcinomatosis: intraoperative parameters in open (coliseum) versus closed abdomen HIPEC. E. Halkia, A. Tsochrinis, D.T. Vassiliadou, et al. International Journal of Surgical Oncology 2015;2015:610597. PubMed · Publisher · Free full text

• Peritoneal metastases from small bowel cancer: Results of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in The Netherlands. T.R. van Oudheusden, V.E. Lemmens, H.J. Braam, et al. Surgery 2015;157(6):1023-7. PubMed · Publisher

• Quantitative analyses at baseline and interim PET evaluation for response assessment and outcome definition in patients with malignant pleural mesothelioma. E. Lopci, P.A. Zucali, G.L. Ceresoli, et al. European Journal of Nuclear Medicine and Molecular Imaging 2015;42(5):667-75. PubMed · Publisher

• Testing mapping algorithms of the cancer-specific EORTC QLQ-C30 onto EQ-5D in malignant mesothelioma. D.T. Arnold, D. Rowen, M.M. Versteegh, et al. Health and Quality of Life Outcomes 2015;13:6. PubMed · Publisher · Free full text

• Tissue Xpert™ MTB/Rif assay is of limited use in diagnosing peritoneal tuberculosis in patients with exudative ascites. C. Bera, J.S. Michael, D. Burad, et al. Indian Journal of Gastroenterology 2015;34(5):395-8. PubMed · Publisher

• Use of computed tomography and positron emission tomography/computed tomography for staging of local extent in patients with malignant pleural mesothelioma. T. Frauenfelder, P. Kestenholz, R. Hunziker, et al. Journal of Computer Assisted Tomography 2015;39(2):160-5. PubMed · Publisher

• Development of a testing method for asbestos fibers in treated materials of asbestos containing wastes by transmission electron microscopy. T. Yamamoto, A. Kida, Y. Noma, et al. Waste Management 2014;34(2):536-41. PubMed · Publisher

• Evaluation of take-home exposure and risk associated with the handling of clothing contaminated with chrysotile asbestos. J. Sahmel, C.A. Barlow, B. Simmons, et al. Risk Analysis 2014;34(8):1448-68. PubMed · Publisher

• Intraperitoneal chemotherapy for peritoneal surface malignancy: experience with 1,000 patients. E.A. Levine, J.H. Stewart, P. Shen, et al. Journal of the American College of Surgeons 2014;218(4):573-85. PubMed · Publisher · Free full text

• Morphological changes during enhanced carbonation of asbestos containing material and its comparison to magnesium silicate minerals. G. Gadikota, C. Natali, C. Boschi, et al. Journal of Hazardous Materials 2014;264:42-52. PubMed · Publisher

• Nuclear expression of STAT6 distinguishes solitary fibrous tumor from histologic mimics. L.A. Doyle, M. Vivero, C.D. Fletcher, et al. Modern Pathology 2014;27(3):390-5. PubMed · Publisher

• Preoperative computed tomography does not predict resectability in peritoneal carcinomatosis. J.D. Rivard, W.J. Temple, Y.J. McConnell, et al. American Journal of Surgery 2014;207(5):760-4; discussion 764-5. PubMed · Publisher

• Progression free survival rate at 9 and 18 weeks predict overall survival in patients with malignant pleural mesothelioma: an individual patient pooled analysis of 10 European Organisation for Research and Treatment of Cancer Lung Cancer Group studies and an independent study validation. B. Hasan, L. Greillier, A. Pallis, et al. European Journal of Cancer 2014;50(16):2771-82. PubMed · Publisher

• The association of 18F-FDG PET/CT parameters with survival in malignant pleural mesothelioma. A. Klabatsa, S. Chicklore, S.F. Barrington, et al. European Journal of Nuclear Medicine and Molecular Imaging 2014;41(2):276-82. PubMed · Publisher

• The relationship between various exposure metrics for elongate mineral particles (EMP) in the taconite mining and processing industry. J. Hwang, G. Ramachandran, P.C. Raynor, et al. Journal of Occupational and Environmental Hygiene 2014;11(9):613-24. PubMed · Publisher

• Use of automated image analysis in evaluation of Mesothelioma Tissue Microarray (TMA) from National Mesothelioma Virtual Bank. W. Amin, M. Srinivasan, S.Y. Song, et al. Pathology, Research and Practice 2014;210(2):79-82. PubMed · Publisher

• Use of direct versus indirect preparation data for assessing risk associated with airborne exposures at asbestos-contaminated sites. M.P. Goldade, W.P. O'Brien. Journal of Occupational and Environmental Hygiene 2014;11(2):67-76. PubMed · Publisher

• 18F-FDG PET/CT in suspected recurrences of epithelial malignant pleural mesothelioma in asbestos-fibers-exposed patients (comparison to standard diagnostic follow-up). A. Niccoli-Asabella, A. Notaristefano, D. Rubini, et al. Clinical Imaging 2013;37(6):1098-103. PubMed · Publisher

• Comparison of exposure assessment methods in a lung cancer case-control study: performance of a lifelong task-based questionnaire for asbestos and PAHs. E. Bourgkard, P. Wild, M. Gonzalez, et al. Occupational and Environmental Medicine 2013;70(12):884-91. PubMed · Publisher

• Comparison of x-ray films and low-dose computed tomographic scans: demonstration of asbestos-related changes in 2760 nuclear weapons workers screened for lung cancer. A. Miller, S.A. Widman, J.A. Miller, et al. Journal of Occupational and Environmental Medicine 2013;55(7):741-5. PubMed · Publisher

• Intensity-modulated radiotherapy and volumetric-modulated arc therapy for malignant pleural mesothelioma after extrapleural pleuropneumonectomy. J. Krayenbuehl, O. Riesterer, S. Graydon, et al. Journal of Applied Clinical Medical Physics 2013;14(4):4130. PubMed · Publisher · Free full text

• Iterative cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent peritoneal metastases. T.C. Chua, L.E. Quinn, J. Zhao, et al. Journal of Surgical Oncology 2013;108(2):81-8. PubMed · Publisher

• Medicines and the media: news reports of medicines recommended for government reimbursement in Australia. J. Robertson, E.J. Walkom, M.D. Bevan, et al. BMC Public Health 2013;13:489. PubMed · Publisher · Free full text

• Mesothelin expression is a prognostic factor in cholangiocellular carcinoma. R. Nomura, H. Fujii, M. Abe, et al. International Surgery 2013;98(2):164-9. PubMed · Publisher · Free full text

• Potential carcinogenic effects of world trade center dust after intratracheal instillation to Sprague-Dawley rats: first observation. M. Soffritti, L. Falcioni, L. Bua, et al. American Journal of Industrial Medicine 2013;56(2):155-62. PubMed · Publisher

• Risk-based indicators of Canadians' exposures to environmental carcinogens. E. Setton, P. Hystad, K. Poplawski, et al. Environmental Health 2013;12:15. PubMed · Publisher · Free full text

• The diagnosis of malignant mesothelioma in effusion cytology: a reappraisal and results of a multi-institution survey. A. Paintal, K. Raparia, M.F. Zakowski, et al. Cancer Cytopathology 2013;121(12):703-7. PubMed · Publisher

• Validation of prognostic factors in malignant pleural mesothelioma: a retrospective analysis of data from patients seeking compensation from the New South Wales Dust Diseases Board. S.C. Kao, J. Vardy, M. Chatfield, et al. Clinical Lung Cancer 2013;14(1):70-7. PubMed · Publisher

• Value of autofluorescence in video-assisted thoracoscopic surgery in pleural diseases. S.T. Liman, A. Elicora, S. Topcu, et al. The Thoracic and Cardiovascular Surgeon 2013;61(4):350-6. PubMed · Publisher

• Value of Glut-1 and Koc markers in the differential diagnosis of reactive mesothelial hyperplasia, malignant mesothelioma and pulmonary adenocarcinoma. Ö. Üçer, A.F. Dağli, A. Kiliçarslan, et al. Türk Patoloji Dergisi 2013;29(2):94-100. PubMed · Publisher

• Value of laparoscopy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis. L.H. Iversen, P.C. Rasmussen, S. Laurberg. The British Journal of Surgery 2013;100(2):285-92. PubMed · Publisher

• Choice of rating method for assessing occupational asbestos exposure: study for compensation purposes in France. C. Gramond, P. Rolland, A. Lacourt, et al. American Journal of Industrial Medicine 2012;55(5):440-9. PubMed · Publisher

• Clinical significance of circulating miR-126 quantification in malignant mesothelioma patients. M. Tomasetti, S. Staffolani, L. Nocchi, et al. Clinical Biochemistry 2012;45(7-8):575-81. PubMed · Publisher

• Comparison of expert and job-exposure matrix-based retrospective exposure assessment of occupational carcinogens in The Netherlands Cohort Study. N.S. Offermans, R. Vermeulen, A. Burdorf, et al. Occupational and Environmental Medicine 2012;69(10):745-51. PubMed · Publisher

• Evaluation of the national health surveillance program of workers previously exposed to asbestos in Spain (2008). M.G. Gómez, R. Castañeda, V.G. López, et al. Gaceta Sanitaria 2012;26(1):45-50. PubMed · Publisher

• Health-related quality of life in patients with lung cancer: validation of the Mexican-Spanish version and association with prognosis of the EORTC QLQ-LC13 questionnaire. Ó. Arrieta, C. Núñez-Valencia, L. Reynoso-Erazo, et al. Lung Cancer 2012;77(1):205-11. PubMed · Publisher

• Long-term survival after lung-sparing total pleurectomy for locally advanced (International Mesothelioma Interest Group Stage T3-T4) non-sarcomatoid malignant pleural mesothelioma. A. Nakas, E. von Meyenfeldt, K. Lau, et al. European Journal of Cardio-thoracic Surgery 2012;41(5):1031-6. PubMed · Publisher

• Outcomes of cytoreduction with hyperthermic intraperitoneal chemotherapy: our experience at a midwest community hospital. B. Goslin, S. Sevak, A. Siripong, et al. American Journal of Surgery 2012;203(3):383-6; discussion 387. PubMed · Publisher

• Outcomes of repeat cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for the treatment of peritoneal surface malignancy. K.I. Votanopoulos, C. Ihemelandu, P. Shen, et al. Journal of the American College of Surgeons 2012;215(3):412-7. PubMed · Publisher · Free full text

  In plain English

  This study looked back at patients treated at one institution from 1993 to 2010. Each had cancer in the lining of the abdomen (the peritoneum) that came back after an operation called cytoreductive surgery with heated chemotherapy (CRS/HIPEC). Sixty-two patients, a highly selected group drawn from 868 treated with CRS/HIPEC, had a second such operation. Seven of them had malignant mesothelioma. The article does not discuss asbestos.

  After the repeat operation, median survival was 32.2 months for all 62 patients and 21.8 months for the mesothelioma patients. Patients left with no visible tumor (R0/R1) lived a median of 55.7 months. Patients left with visible tumor lived a median of 20.3 months (R2a) and 15.5 months (R2b to R2c). Two patients (3.2%) died within 30 days.

  In the statistical analysis, two things were linked to longer survival: how completely tumor was removed in the second operation, and the time between the two operations. The authors concluded that, for selected patients in experienced centers, a repeat operation carried complication and death rates similar to the first. They noted the study was retrospective, came from one institution, and included patient selection bias.

  We wrote this plain-English summary from the full article with the help of AI, and a second AI model checked each sentence against the article. It is not the authors' wording; the abstract and the article are their own account.

• Pleural mesothelioma surveillance: validity of cases from a tumour registry. F. Labrèche, B.W. Case, G. Ostiguy, et al. Canadian Respiratory Journal 2012;19(2):103-7. PubMed · Publisher · Free full text

• Predictive accuracy of the Liverpool Lung Project risk model for stratifying patients for computed tomography screening for lung cancer: a case-control and cohort validation study. O.Y. Raji, S.W. Duffy, O.F. Agbaje, et al. Annals of Internal Medicine 2012;157(4):242-50. PubMed · Publisher · Free full text

• Response to chemotherapy is predictive in relation to longer overall survival in an individual patient combined-analysis with pleural mesothelioma. J.K. Blayney, G.L. Ceresoli, B. Castagneto, et al. European Journal of Cancer 2012;48(16):2983-92. PubMed · Publisher

• The new case for cervical mediastinoscopy in selection for radical surgery for malignant pleural mesothelioma. A. Nakas, D. Waller, K. Lau, et al. European Journal of Cardio-thoracic Surgery 2012;42(1):72-6; discussion 76. PubMed · Publisher

• The role of FDG PET-CT in differential diagnosis of pleural pathologies. U. Elboga, M. Yılmaz, M. Uyar, et al. Revista Española de Medicina Nuclear e Imagen Molecular 2012;31(4):187-91. PubMed · Publisher

• The validity of static lung compliance in asbestos-induced diseases. J. Schneider, R. Arhelger, W. Raab, et al. Lung 2012;190(4):441-9. PubMed · Publisher

• Three-dimensional stereoscopic volume rendering of malignant pleural mesothelioma. N.M. Mollberg, N.M. Parsad, S.G. Armato, et al. International Surgery 2012;97(1):65-70. PubMed · Publisher · Free full text

• A 3-dimensional in vitro model of epithelioid granulomas induced by high aspect ratio nanomaterials. V.C. Sanchez, P. Weston, A. Yan, et al. Particle and Fibre Toxicology 2011;8:17. PubMed · Publisher · Free full text

• An in vivo platform for tumor biomarker assessment. E.L. Servais, K. Suzuki, C. Colovos, et al. PloS One 2011;6(10):e26722. PubMed · Publisher · Free full text

• Apples to apples: the origin and magnitude of differences in asbestos cancer risk estimates derived using varying protocols. D.W. Berman. Risk Analysis 2011;31(8):1308-26. PubMed · Publisher

• Artificial geochemical barriers for additional recovery of non-ferrous metals and reduction of ecological hazard from the mining industry waste. V. Chanturiya, V. Masloboev, D. Makarov, et al. Journal of Environmental Science and Health. Part A, Toxic/hazardous Substances & Environmental Engineering 2011;46(13):1579-87. PubMed · Publisher

• Cytotoxicity and solubility evaluation of two types of whiskers by cell magnetometry. Y. Kudo, Y. Aizawa. Environmental Health and Preventive Medicine 2011;16(5):327-34. PubMed · Publisher · Free full text

• Durability and inflammogenic impact of carbon nanotubes compared with asbestos fibres. M.J. Osmond-McLeod, C.A. Poland, F. Murphy, et al. Particle and Fibre Toxicology 2011;8:15. PubMed · Publisher · Free full text

• Evaluation of asbestos exposure during brake repair and replacement. H. Kakooei, M. Hormozy, H. Marioryad. Industrial Health 2011;49(3):374-80. PubMed · Publisher

• Government and Navy knowledge regarding health hazards of asbestos: a state of the science evaluation (1900 to 1970). K. Franke, D. Paustenbach. Inhalation Toxicology 2011;23 Suppl 3:1-20. Review PubMed · Publisher

• Identifying patients with suspected lung cancer in primary care: derivation and validation of an algorithm. J. Hippisley-Cox, C. Coupland. The British Journal of General Practice 2011;61(592):e715-23. PubMed · Publisher · Free full text

• Markers for the non-invasive diagnosis of mesothelioma: a systematic review. S. van der Bij, E. Schaake, H. Koffijberg, et al. British Journal of Cancer 2011;104(8):1325-33. Systematic review PubMed · Publisher · Free full text

• Performance of biomarkers SMRP, CA125, and CYFRA 21-1 as potential tumor markers for malignant mesothelioma and lung cancer in a cohort of workers formerly exposed to asbestos. M. Gube, D. Taeger, D.G. Weber, et al. Archives of Toxicology 2011;85(3):185-92. PubMed · Publisher

• Validation of a minimal panel of antibodies for the diagnosis of malignant pleural mesothelioma. S.C. Kao, K. Griggs, K. Lee, et al. Pathology 2011;43(4):313-7. PubMed · Publisher

• Validation of tissue microarray technology in malignant pleural mesothelioma. S.C. Kao, K. Lee, N.J. Armstrong, et al. Pathology 2011;43(2):128-32. PubMed · Publisher

• Vascular endothelial growth factor in pleural fluid for differential diagnosis of benign and malignant origin and its clinical applications. A. Fiorelli, G. Vicidomini, M. Di Domenico, et al. Interactive Cardiovascular and Thoracic Surgery 2011;12(3):420-4. PubMed · Publisher

• A diagnostic assay based on microRNA expression accurately identifies malignant pleural mesothelioma. H. Benjamin, D. Lebanony, S. Rosenwald, et al. The Journal of Molecular Diagnostics 2010;12(6):771-9. PubMed · Publisher · Free full text

• Awake video-assisted pleural decortication for empyema thoracis. F. Tacconi, E. Pompeo, E. Fabbi, et al. European Journal of Cardio-thoracic Surgery 2010;37(3):594-601. PubMed · Publisher

• Combined FDG-PET/CT in response evaluation of malignant pleural mesothelioma. P. Veit-Haibach, N.G. Schaefer, H.C. Steinert, et al. Lung Cancer 2010;67(3):311-7. PubMed · Publisher

• Development of an enzyme-linked immunosorbent assay for the detection of human calretinin in plasma and serum of mesothelioma patients. I. Raiko, I. Sander, D.G. Weber, et al. BMC Cancer 2010;10:242. PubMed · Publisher · Free full text

• Development of the releasable asbestos field sampler. J.R. Kominsky, J.W. Thornburg, G.M. Shaul, et al. Journal of the Air & Waste Management Association 2010;60(3):294-301. PubMed · Publisher

• Diagnosis and origin determination of malignant pleural effusions through the use of the breast cancer marker human mammaglobin. S. Roncella, P. Ferro, M.C. Franceschini, et al. Diagnostic Molecular Pathology 2010;19(2):92-8. PubMed · Publisher

• Diagnostic performance of soluble mesothelin and megakaryocyte potentiating factor in mesothelioma. K. Hollevoet, K. Nackaerts, J. Thimpont, et al. American Journal of Respiratory and Critical Care Medicine 2010;181(6):620-5. PubMed · Publisher

• Effect of a two-hour training on physicians' skill in interpreting Pneumoconiotic chest radiographs. N.R. Ngatu, S. Suzuki, Y. Kusaka, et al. Journal of Occupational Health 2010;52(5):294-301. PubMed · Publisher

• Efficacy of intra-operative unilateral diaphragm plication for patients undergoing unilateral phrenicotomy during extended surgery. T. Tokunaga, N. Sawabata, Y. Kadota, et al. European Journal of Cardio-thoracic Surgery 2010;38(5):600-3. PubMed · Publisher

• Emissions concerns during renovation in the healthcare setting: asbestos abatement of floor tile and mastic in medical facilities. W.P. Racine. Journal of Environmental Management 2010;91(7):1429-36. PubMed · Publisher

• Evaluation of exposure to the airborne asbestos in an automobile brake and clutch manufacturing industry in Iran. H. Kakooei, H. Marioryad. Regulatory Toxicology and Pharmacology 2010;56(2):143-7. PubMed · Publisher

• High blood neutrophil-to-lymphocyte ratio is an indicator of poor prognosis in malignant mesothelioma patients undergoing systemic therapy. S.C. Kao, N. Pavlakis, R. Harvie, et al. Clinical Cancer Research 2010;16(23):5805-13. PubMed · Publisher

• Immunocytochemistry of CD146 is useful to discriminate between malignant pleural mesothelioma and reactive mesothelium. A. Sato, I. Torii, Y. Okamura, et al. Modern Pathology 2010;23(11):1458-66. PubMed · Publisher

• Malignant peritoneal mesothelioma: a multicenter study on 81 cases. V.P. Manzini, L. Recchia, M. Cafferata, et al. Annals of Oncology 2010;21(2):348-353. PubMed · Publisher

• Managing the pneumonectomy space after extrapleural pneumonectomy: postoperative intrathoracic pressure monitoring. A.S. Wolf, F.L. Jacobson, T.R. Tilleman, et al. European Journal of Cardio-thoracic Surgery 2010;37(4):770-5. PubMed · Publisher

• Preliminary study of positron emission tomography/computed tomography and plasma osteopontin levels in patients with asbestos-related pleural disease. S. Kurata, M. Ishibashi, K. Azuma, et al. Japanese Journal of Radiology 2010;28(6):446-52. PubMed · Publisher

• Producing samples for the organization of proficiency tests. Study of the homogeneity of replicas produced from two atmosphere generation systems. L. Freville, J.C. Moulut, M. Grzebyk, et al. The Annals of Occupational Hygiene 2010;54(6):659-70. PubMed · Publisher

• Retinol supplementation and mesothelioma incidence in workers earlier exposed to blue asbestos (Crocidolite) at Wittenoom, Western Australia. H.S. Alfonso, A. Reid, N.H. de Klerk, et al. European Journal of Cancer Prevention 2010;19(5):355-9. PubMed · Publisher

• Staging algorithm for diffuse malignant pleural mesothelioma. M. Zielinski, J. Hauer, L. Hauer, et al. Interactive Cardiovascular and Thoracic Surgery 2010;10(2):185-9. PubMed · Publisher

• SV40 associated miRNAs are not detectable in mesotheliomas. G.V. Gee, M.L. Stanifer, B.C. Christensen, et al. British Journal of Cancer 2010;103(6):885-8. PubMed · Publisher · Free full text

• The diagnostic utility of maspin in the distinction between malignant mesothelioma and pulmonary adenocarcinoma. E.U. Akyildiz, B. Oz, I. Sehitoglu, et al. The Journal of International Medical Research 2010;38(3):1070-6. PubMed · Publisher

• The role of endobronchial ultrasound guided transbronchial needle aspiration cytology in the investigation of mediastinal lymphadenopathy and masses, the North Tees experience. S. Natu, J. Hoffman, M. Siddiqui, et al. Journal of Clinical Pathology 2010;63(5):445-51. PubMed · Publisher

2000s

• An evaluation of short-term exposures of brake mechanics to asbestos during automotive and truck brake cleaning and machining activities. R.O. Richter, B.L. Finley, D.J. Paustenbach, et al. Journal of Exposure Science & Environmental Epidemiology 2009;19(5):458-74. PubMed · Publisher
• Application of portable Raman instruments for fast and non-destructive detection of minerals on outcrops. J. Jehlicka, P. Vítek, H.G. Edwards, et al. Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy 2009;73(3):410-9. PubMed · Publisher
• Circulating mesothelin protein and cellular antimesothelin immunity in patients with pancreatic cancer. F.M. Johnston, M.C. Tan, B.R. Tan, et al. Clinical Cancer Research 2009;15(21):6511-8. PubMed · Publisher · Free full text
• Comparative assessing for radiological, chemical, and physical exposures at the French uranium conversion plant: Is uranium the only stressor?. I. Guseva Canu, F. Paquet, M. Goldberg, et al. International Journal of Hygiene and Environmental Health 2009;212(4):398-413. PubMed · Publisher
• Efficiency of sampling and analysis of asbestos fibers on filter media: implications for exposure assessment. D.A. Vallero, J.R. Kominsky, M.E. Beard, et al. Journal of Occupational and Environmental Hygiene 2009;6(1):62-72. PubMed · Publisher
• Evaluation of the dose calculation accuracy in intensity-modulated radiation therapy for mesothelioma, focusing on low doses to the contralateral lung. L.E. Court, D. Ching, D. Schofield, et al. Journal of Applied Clinical Medical Physics 2009;10(2):34-42. PubMed · Publisher · Free full text
• Exhaled breath condensate biomarkers in asbestos-related lung disorders. S. Chow, C. Campbell, A. Sandrini, et al. Respiratory Medicine 2009;103(8):1091-7. PubMed · Publisher
• Integration of serpentine channels for microchip electrophoresis with a palladium decoupler and electrochemical detection. A.L. Bowen, R.S. Martin. Electrophoresis 2009;30(19):3347-54. PubMed · Publisher · Free full text
• Performance of chest radiograph and CT scan for lung cancer screening in asbestos-exposed workers. B. Clin, F. Morlais, L. Guittet, et al. Occupational and Environmental Medicine 2009;66(8):529-34. PubMed · Publisher
• Rapid and easy method for monitoring oxidative stress markers in body fluids of patients with asbestos or silica-induced lung diseases. K. Syslová, P. Kacer, M. Kuzma, et al. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences 2009;877(24):2477-86. PubMed · Publisher
• Utilization of the seagrass Posidonia oceanica to evaluate the spatial dispersion of metal contamination. C. Lafabrie, G. Pergent, C. Pergent-Martini. The Science of the Total Environment 2009;407(7):2440-6. PubMed · Publisher
• Development and validation of a lung cancer risk prediction model for African-Americans. C.J. Etzel, S. Kachroo, M. Liu, et al. Cancer Prevention Research 2008;1(4):255-65. PubMed · Publisher · Free full text
• Outcome after extrapleural pneumonectomy for malignant pleural mesothelioma. C. Aigner, M.A. Hoda, G. Lang, et al. European Journal of Cardio-thoracic Surgery 2008;34(1):204-7. PubMed · Publisher
• The LLP risk model: an individual risk prediction model for lung cancer. A. Cassidy, J.P. Myles, M. van Tongeren, et al. British Journal of Cancer 2008;98(2):270-6. PubMed · Publisher · Free full text
• The quality of fiber counts using improved slides with relocatable fields. T.W. Pang, M. Harper. Journal of Environmental Monitoring 2008;10(1):89-95. PubMed · Publisher
• Update of potency factors for asbestos-related lung cancer and mesothelioma. D.W. Berman, K.S. Crump. Critical Reviews in Toxicology 2008;38 Suppl 1:1-47. PubMed · Publisher
• Variability in interpretation among B-readers in the U.S. Navy Asbestos Medical Surveillance Program. J.G. Muller, J.M. Lieske, J.E. Hernandez, et al. Military Medicine 2008;173(4):375-80. PubMed · Publisher
• Changes in B-readings over time in the United States Navy Asbestos Medical Surveillance Program. J.G. Muller, W.G. Rudolph, J.M. Lieske, et al. Journal of Occupational and Environmental Medicine 2007;49(2):194-203. PubMed · Publisher
• Degradation, bioactivity, and cytocompatibility of diopside, akermanite, and bredigite ceramics. C. Wu, J. Chang. Journal of Biomedical Materials Research. Part B, Applied Biomaterials 2007;83(1):153-60. PubMed · Publisher
• Mesothelin family proteins and diagnosis of mesothelioma: analytical evaluation of an automated immunoassay and preliminary clinical results. F. Di Serio, A. Fontana, M. Loizzi, et al. Clinical Chemistry and Laboratory Medicine 2007;45(5):634-8. PubMed · Publisher
• Meta-analysis of several gene lists for distinct types of cancer: a simple way to reveal common prognostic markers. X. Yang, X. Sun. BMC Bioinformatics 2007;8:118. PubMed · Publisher · Free full text
• Performance of membrane filters used for TEM analysis of asbestos. J.S. Webber, A.G. Czuhanich, L.J. Carhart. Journal of Occupational and Environmental Hygiene 2007;4(10):780-9. PubMed · Publisher
• The Portsmouth thoracoscopy experience, an evaluation of service by retrospective case note analysis. S.V. Fletcher, R.J. Clark. Respiratory Medicine 2007;101(5):1021-5. PubMed · Publisher
• Toxicity and carcinogenicity mechanisms of fibrous antigorite. V. Cardile, L. Lombardo, E. Belluso, et al. International Journal of Environmental Research and Public Health 2007;4(1):1-9. PubMed · Publisher · Free full text
• A multi-class predictor based on a probabilistic model: application to gene expression profiling-based diagnosis of thyroid tumors. N. Yukinawa, S. Oba, K. Kato, et al. BMC Genomics 2006;7:190. PubMed · Publisher · Free full text
• Copy number gains on 5p15, 6p11-q11, 7p12, and 8q24 are rare in sputum cells of individuals at high risk of lung cancer. E. Kettunen, K. Salmenkivi, K. Vuopala, et al. Lung Cancer 2006;54(2):169-76. PubMed · Publisher
• Asbestos abatement of pipe and floor tile/mastic and comparison of critical plastic barrier controls. J.H. Lange. Bulletin of Environmental Contamination and Toxicology 2004;72(3):542-6. PubMed · Publisher
• Assessment of 18F-fluorodeoxyglucose dual-head gamma camera in asbestos lung diseases. B. Melloni, J. Monteil, F. Vincent, et al. The European Respiratory Journal 2004;24(5):814-21. PubMed · Publisher
• Surveillance of Australian workplace Based Respiratory Events (SABRE): notifications for the first 3.5 years and validation of occupational asthma cases. D. Elder, M. Abramson, D. Fish, et al. Occupational Medicine 2004;54(6):395-9. PubMed · Publisher
• [(18)F]-FDG PET and localized fibrous mesothelioma. J. Cortes, J. Rodriguez, M.J. Garcia-Velloso, et al. Lung 2003;181(1):49-54. Case report · Review PubMed · Publisher
• Calculation of fractions of lung cancer incidence attributable to occupational exposure to asbestos and combustion products in Stockholm, Sweden. P. Gustavsson, A. Ahlbom, T. Andersson, et al. European Journal of Epidemiology 2003;18(10):937-40. PubMed · Publisher
• Comparison of physiological and subjective strain in workers wearing two different protective coveralls for asbestos abatement tasks. E. Turpin-Legendre, J.P. Meyer. Applied Ergonomics 2003;34(6):551-6. PubMed · Publisher
• Determination of low levels of free fibres of chrysotile in contaminated soils by X-ray diffraction and FTIR spectroscopy. E. Foresti, M. Gazzano, A.F. Gualtieri, et al. Analytical and Bioanalytical Chemistry 2003;376(5):653-8. PubMed · Publisher
• Evaluation of the catalytic activity of lipases immobilized on chrysotile for esterification. J.E. Silva, P.C. Jesus. Anais Da Academia Brasileira de Ciências 2003;75(2):157-62. PubMed · Publisher
• Asbestos fibreyears and lung cancer: a two phase case-control study with expert exposure assessment. H. Pohlabeln, P. Wild, W. Schill, et al. Occupational and Environmental Medicine 2002;59(6):410-4. PubMed · Publisher · Free full text
• Computed tomography features in malignant pleural mesothelioma and other commonly seen pleural diseases. M. Metintas, I. Ucgun, O. Elbek, et al. European Journal of Radiology 2002;41(1):1-9. PubMed · Publisher
• Fine-needle aspiration biopsy of axillary lymph nodes. S. Jaffer, M. Zakowski. Diagnostic Cytopathology 2002;26(2):69-74. PubMed · Publisher
• Immunohistochemistry in the distinction between malignant mesothelioma and pulmonary adenocarcinoma: a critical evaluation of new antibodies. A.S. Abutaily, B.J. Addis, W.R. Roche. Journal of Clinical Pathology 2002;55(9):662-8. PubMed · Publisher · Free full text
• Performance of power assisted respirators during simulated asbestos removal. M.P. Clayton, A.E. Bailey, N.P. Vaughan, et al. The Annals of Occupational Hygiene 2002;46(1):49-59. PubMed · Publisher
• Combined use of novel epithelial (MOC-31) and mesothelial (HBME-1) immunohistochemical markers for optimal first line diagnostic distinction between mesothelioma and metastatic carcinoma in pleura. C. González-Lois, C. Ballestín, M.T. Sotelo, et al. Histopathology 2001;38(6):528-34. PubMed · Publisher
• Comparison of antibodies to HBME-1 and calretinin for the detection of mesothelial cells in effusion cytology. P.A. Fetsch, A. Simsir, A. Abati. Diagnostic Cytopathology 2001;25(3):158-61. PubMed · Publisher
• Evaluation of pleural disease using MR and CT. With special reference to malignant pleural mesothelioma. A. Knuuttila, L. Kivisaari, A. Kivisaari, et al. Acta Radiologica 2001;42(5):502-7. PubMed · Publisher
• Functional consequences of pleural disease evaluated with chest radiography and CT. S.J. Copley, A.U. Wells, M.B. Rubens, et al. Radiology 2001;220(1):237-43. PubMed · Publisher
• Staining of malignant mesothelioma for the trefoil protein pS2. E. Murphy, S.K. Suvarna. Histopathology 2001;38(4):381-2. Letter PubMed · Publisher
• The role of metals in autoimmune vasculitis: epidemiological and pathogenic study. P. Stratta, A. Messuerotti, C. Canavese, et al. The Science of the Total Environment 2001;270(1-3):179-90. PubMed · Publisher
• Value of p63 and cytokeratin 5/6 as immunohistochemical markers for the differential diagnosis of poorly differentiated and undifferentiated carcinomas. O. Kaufmann, E. Fietze, J. Mengs, et al. American Journal of Clinical Pathology 2001;116(6):823-30. PubMed · Publisher

Browse every journal in the library or other types of article.